10 startups fueling pharma in social media; 5 promising preclinical programs;

Biotech IT News

> 10 startups fueling pharma in social media. Special report

> Fierce's Top 10 Biotech Techies - 2013. Special report

> GSK jumps new IT hurdles in 'real-world' test of blockbuster hopeful. Article

> Fierce's top 5 feats in life sciences 'gamification.' Special report

> 20 Big Pharma and biotech mobile apps - 2013. Special report

CRO News

> DIA 2013: Big or small, CROs need clout to survive. Editor's corner

> CRO turnover rate sky-high, according to survey. Article

> KKR buying RPS, planning to merge it with PRA. Story

> Outsourcing in China: Big Pharma wants partners, not just contractors. More

> FierceCRO at DIA 2013. Slideshow

Biotech Research News

> 5 promising preclinical programs. Special report

> New drug repairs brain connections lost in Alzheimer's. Article

> Sequester cuts come down heavy on scientific, medical research. Story

> Chemical in red wine kills cancer cells even after it's metabolized. More

> Bristol, AZ take doses of Vanderbilt to treat depressed CNS drug R&D. Item

PharmaManufacturing News

> BD quickly rolling out second drug from new injectables plant. Article

> Pfizer's effort to confront shortage leads to second Levoxyl recall. Story

> Hospira moves forward with two plants in India. More

> New manufacturing issues lead AbbVie to 2nd Synthroid recall. Story

> Conquering the complexities of biologics to get to biosimilars. Special report

Diagnostics News

> Roche looks to the future with two new molecular Dx systems. Article

> Roche to close 454 Life Sciences as it reduces gene sequencing focus. Story

> Q3's top 5 diagnostics VC deals. Special report

> Roche, Pacific Biosciences forge clinical Dx deal. More

> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Article

Drug Delivery News

> Roundup: Insulin delivery devices at ADA. Article

> The Future of Nanotech Drug Delivery. Special report

> The race for the artificial pancreas. Special report

> 'Smart' insulin nanoparticle controls blood sugar levels for up to 10 days. Story

> Pfizer launches first U.S. once-daily liquid ADHD drug. Article

Biomarkers News

> Bill Gates helps genomic tests startup lay firm foundation. Article

> Brain biomarker may help open door to personalized depression drugs. Story

> CV biomarker study finds evidence of bias, exaggeration in the field. More

> 12-year study flags new biomarker for high risk of diabetes. Story

> Luminex to collaborate with Merck on Alzheimer's biomarker diagnostic. Article

Vaccines News

> Top 5 Vaccine Companies by Revenue - 2012. Special report

> Type 1 diabetes vaccine impresses in early study. Article

> ABC's appointment of Jenny McCarthy sparks media furor. More

> Major FDA vaccine approvals of 2012. Special report

> Pfizer's Prevnar 13, GSK's Synflorix pump up vaccination cost. Story

Suggested Articles

It’s been a good year for Intellia: One of its founders, Jennifer Doudna, Ph.D., nabbed the Nobel Prize in Chemistry for her CRISPR research.

After stints at Eli Lilly, Boehringer Ingelheim and Bristol Myers Squibb, Sid Kerkar, M.D., is hopping over to a small biotech.

Two long noncoding RNAs called TROLL-2 and TROLL-3 influence protein signaling to drive the progression of breast cancer, a new study revealed.